|
Reports
of recent clinical trial data
Contributors
were selected by Gwyn Bebb, BMBCh, PhD, FR CPC; Joseph Ragaz,
MD, FRCPC; and Neil Reaume, BSc, MD, FRCPC, MSc.
|
To view the clinical trial data of the following topics click
here (pdf format)
Prostate
cancer
Bone health in men receiving androgen
deprivation therapy
Christina M. Canil, MD, FRCPC, Medical
Oncologist, The Ottawa Hospital Cancer Centre, Assistant Professor,
Department of Medicine, University of Ottawa, Ottawa ON
TRIAL SUMMARY: Denosumab for prevention of fractures
Non-small
cell lung cancer
Treatment of advanced disease
Cheryl Ho, MD, FRCPC, Medical Oncologist,
British Columbia Cancer Agency; Clinical Assistant Professor of
Medicine, University of British Columbia, Vancouver, BC
STUDY SUMMARY: Gefitinib monotherapy
Molecular-based
treatment
Gwyn Bebb, BMBCh, PhD, FRCPC,
Medical Oncologist, Tom Baker Cancer Centre; Assistant Professor,
University of Calgary, Calgary, AB
STUDY SUMMARY: Predictive value of KRAS status
in NSCLC
Breast
cancer
Combining targeted therapies in women
with metastatic breast cancer
Caroline Lohrisch, MD, FRCPC, Medical
Oncologist, British Columbia Cancer Agency.
TRIAL SUMMARY: Lapatinib + trastuzumab in women with MBC
Prevention
Joseph Ragaz, MD, FRCPC, Clinical
Professor, Medicine, School of Population & Public Health, University
of British Columbia; Adjunct Professor Medicine & Oncology,
McGill University, Montreal, Quebec
TRIAL SUMMARY: Oral Bisphosphonates and Breast Cancer Prevention.
Hormonal therapy
in postmenopausal early breast cancer
Shailendra Verma, MD, FRCPC, FACP,
Medical Oncologist, Ottawa Hospital Regional Cancer Centre; Associate
Professor, Department of Medicine, University of Ottawa
TRIAL SUMMARY: Exemestane vs tamoxifen followed by exemestane
TRIAL SUMMARY: Tamoxifen followed by exemestane vs tamoxifen
To view the clinical trial data click
here (pdf format)
|
